These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21261737)

  • 1. Education and imaging: hepatobiliary and pancreatic: focal steatohepatitis mimicking a metastasis.
    Choi JS; Kim MJ
    J Gastroenterol Hepatol; 2011 Feb; 26(2):415. PubMed ID: 21261737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Focal fatty liver -- often difficult differential diagnosis of liver metastasis].
    Petrik M; Zimmermann U; Woenckhaus C
    Rofo; 2004 Mar; 176(3):422-4. PubMed ID: 15026960
    [No Abstract]   [Full Text] [Related]  

  • 3. Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases.
    Fumal I; Danchin A; Cosserat F; Barbaud A; Schmutz JL
    Dermatology; 2005; 210(3):251-2. PubMed ID: 15785062
    [No Abstract]   [Full Text] [Related]  

  • 4. Education and imaging. Hepatobiliary and pancreatic: Multinodular fatty liver associated with porphyria cutanea tarda.
    Emamaullee JA; Thiesen A; Owen RJ; Shapiro AM
    J Gastroenterol Hepatol; 2011 Jan; 26(1):211. PubMed ID: 21175820
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist.
    Ahmed MH; Osman KA
    Breast Cancer Res Treat; 2006 May; 97(2):223-4. PubMed ID: 16322887
    [No Abstract]   [Full Text] [Related]  

  • 6. Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate.
    Ogawa Y; Murata Y; Saibara T; Nishioka A; Kariya S; Yoshida S
    Oncol Rep; 2003; 10(5):1473-8. PubMed ID: 12883726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen: to use or not to use.
    Yin CS
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):129-30. PubMed ID: 18400603
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen and growth of an extrauterine leiomyoma.
    Bayya J; Minkoff H; Khulpateea N
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):90-1. PubMed ID: 18848745
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen-related vasculitis.
    Baptista MZ; Prieto VG; Chon S; Hortobagyi GN; Esteva FJ
    J Clin Oncol; 2006 Jul; 24(21):3504-5. PubMed ID: 16849770
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen and the singing voice.
    Herxheimer A
    PLoS Med; 2005 Sep; 2(9):e310. PubMed ID: 16173841
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-up of patients with early breast cancer.
    Sakemi H
    N Engl J Med; 2007 Sep; 357(10):1052-3; author reply 1053. PubMed ID: 17804856
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic breast cancer presenting with diabetes insipidus.
    Van de Velde A; Wassenaar H; Strubbe A; Janssen P; Verhaert G
    JBR-BTR; 2000 Apr; 83(2):68-70. PubMed ID: 10859899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The imaging diagnosis of tumor-like multi-nodule fatty liver].
    Wang ZQ; Ji XM; Xu J; Chen ZQ; Lu GM; Li JS
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):114-5. PubMed ID: 14980125
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.
    Georgopoulos NA; Adonakis GL; Fotopoulos A; Koika V; Spinos N; Saltamavros A; Keramopoulos A; Koukouras D; Decavalas G; Kourounis GS
    Gynecol Endocrinol; 2006 Apr; 22(4):185-9. PubMed ID: 16723304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expert consensus on the diagnosis and treatment of bone metastasis and skeletal related events in breast cancer patients].
    Collaborating study group on breast cancer bone metastasis
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):156-9. PubMed ID: 19538898
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL; Cheng MH; Chao HT; Wang PH
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some antidepressants interfere with tamoxifen more than others.
    Harv Womens Health Watch; 2010 Mar; 17(7):6. PubMed ID: 20480970
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
    Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
    Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer.
    Rodríguez-Rodríguez LM; Rodríguez-Rodríguez EM; Oramas-Rodríguez JM; Santolaria-Fernandez F; Llanos M; Cruz J; Martínez A; González-Reimers E; Gómez A; Batista N
    Breast Cancer Res Treat; 2005 Sep; 93(1):75-83. PubMed ID: 16184462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.